Me. Goldsmith et al., WILD-TYPE P53 STIMULATES EXPRESSION FROM THE HUMAN MULTIDRUG-RESISTANCE PROMOTER IN A P53-NEGATIVE CELL-LINE, The Journal of biological chemistry, 270(4), 1995, pp. 1894-1898
The effect of human wild type and mutant p53 proteins on the human mul
tidrug resistance (MDR1) promoter was studied in a p53-negative human
cell line. Transient expression of MDR1 promoter-chloramphenicol acety
ltransferase reporter gene constructs (MDRCAT) cotransfected with p53
expression vectors was analyzed in H358 lung carcinoma cells. Cotransf
ection with a wild type p53 expression vector stimulated MDRCAT activi
ty, while cotransfection with mutant p53 expression vectors altered at
amino acid positions 181, 252, 258, or 273 failed to stimulate expres
sion, Wild type p53 stimulation of MDRCAT activity was time dependent
with maximal expression occurring 24-30 h following transfection and c
orrelating with high p53 protein levels, MDR1 promoter deletion analys
is suggested that the sequences involved in wild type p53 stimulation
of MDRCAT activity were contained within the region from -39 to +53 re
lative to the start of transcription at +1. This region contains no TA
TA or p53 consensus binding sequence but does contain an initiator seq
uence. Wild type p53 stimulation of MDRCAT expression also occurred in
parental and doxorubicin-resistant SW620 colon and parental 2780 ovar
ian cancer cell lines, indicating that wild type p53-mediated simulati
on of the MDR1 promoter is not restricted to a single cell line.